Estrogen regulates somatostatin receptor subtype 2 messenger ribonucleic acid expression in human breast cancer cells

Endocrinology

Volumn 137, Issue 12, 1996, Pages 5634-5640

  Xu, Yun ^a   Song, Jinfen ^b   Berelowitz, Michael ^a   Bruno, John F ^a  

^a STONY BROOK UNIVERSITY   (United States)

^b SUNY at Stony Brook ^*

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYTAMOXIFEN; ANTIESTROGEN; ESTRADIOL; ESTROGEN; FULVESTRANT; MESSENGER RNA; NUCLEASE; RECEPTOR SUBTYPE; SOMATOSTATIN RECEPTOR;

ARTICLE; AUTORADIOGRAPHY; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CONTROLLED STUDY; CULTURE MEDIUM; DOSE RESPONSE; ENZYME ASSAY; GENE EXPRESSION REGULATION; HORMONAL REGULATION; HUMAN; HUMAN CELL; HYBRIDIZATION; PRIORITY JOURNAL; RECEPTOR BINDING; RNA ANALYSIS;

EID: 0030474240     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.137.12.8940394     Document Type: Article

References (34)

1. Reichlin S 1983 Somatostatin. N Engl J Med 309:1495-1501, 1556-1563
2. Schally AV 1988 Oncological applications of somatostatin analogs. Cancer Res 48:6977-6985
3. Lamberts SWJ, Krenning EP, Reubi JC 1991 The role of somatostatin and its analogs in the diagnosis and treatment of tumors. Endocr Rev 12:450-482
4. Marbach P, Neufeld M, Pless J 1985 Clinical application of somatostatin analogs. Adv Exp Mod Biol 188:339-353
5. Weber C, Merriam L, Koschitzky T, Karp F, Benson M, Forde K, LoGerfo P 1989 Inhibition of growth of human breast carcinomas in vivo by somatostatin analog SMS 201-995: treatment of nude mouse xenografts. Surgery 106:416-422
6. Setyono-Han B, Henkelman MS, Foekens JA, Klijn JG 1987 Direct inhibitory effects of somatostatin analogues on the growth of human breast cancer cells. Cancer Res 47:1566-1570
7. Weckbecker G, Raulf F, Stolz B, Bruns C 1993 Somatostatin analogs for diagnosis and treatment of cancer. Pharmacol Thor 60:245-264
8. Liebow C, Reilly C, Serrano M, Schally AV 1989 Somatostatin analogues inhibit growth of pancreatic cancer by stimulating tyrosine phosphatase. Proc Natl Acad Sci USA 86:2003-2007
9. Qin Y, Ertl T, Groot K, Horvath J, Cai R-Z, Schally AV 1995 Somatostatin analog RC-160 inhibits growth of CFPAC-1 human pancreatic cancer cells in vitro and intracellular production of cyclic adenosine monopnosphate. Int J Cancer 60:694-700
10. Hierowski MT, Liebow C, du Sapin K, Schally AV 1985 Stimulation by somatostatin of dephosphorylation of membrane proteins in pancreatic cancer MIA PaCa-2 cell line. FEBS Lett 179:252-256
11. Reisine T, Bell G 1995 Molecular biology of somatostatin receptors. Endocr Rev 16:427-442
12. El-Ashry D, Lippman ME 1994 Molecular biology of breast carcinoma. World J Surg 18:12-20
13. 1 colls. Endocrinology 136:5070-5075
14. Kimura N, Hayafuji C, Konagaya H, Takahashi K 1986 17β-Estradiol induces somatostatin (SRIF). Inhibition of prolactin release and regulates SRIF receptors in rat anterior pituitary cells. Endocrinology 119:1028-1036
15. Slama A, Videau C, Kordan C, Epelbaum J 1992 Estradiol regulation of somatostatin receptors in the arcuate nucleus of the female rat. Neuroendocrinology 56:240-245
16. White JD, Stewart KD, McKelvy JF 1986 Measurement of neuroendocrine peptide mRNA in discrete brain regions. In: Conn PM (ed) Methods in Enzymology. Academic Press, Orlando, vol 124:548-560
17. Bruno JF, Xu Y, Song J, Berelowitz M 1993 Tissue distribution of somatostatin receptor subtype messenger ribonucleic acid in the rat. Endocrinology 133:2561-2567
18. Antoniotti H, Fagot-Revurat P, Esteve JP, Fourmy D, Pradayol L, Ribet A 1984 Purification of radioiodinated somatostatin-related peptides by reversedphase high-performance liquid chromatography. J Chromatogr 296:181-188
19. Munson PJ, Rodbard D 1980 A versatile computerised approach for the characterization of ligand binding systems. Anal Biochem 107:220-239
20. Eden PA, Taylor JE 1993 Somatostatin receptor subtype gene expression in human and rodent tumors. Life Sci 53:85-90
21. Vikic-Topic S, Raisch KP, Kvols LK, Vuk-Pavlovic S 1995 Expression of somatostatin receptor subtypes in breast carcinoma, carcinoid tumor, and renal cell carcinoma. J Clin Endocrinol Metab 80:2974-2979
22. Hatzoglou A, Ouafik L'H, Bakogeorgou E, Thermos K, Castanas E 1995 Morphine cross-reacts with somatostatin receptor sstr2 in the T47D human breast cancer cell line and decreases cell growth. Cancer Res 55:5632-5636
23. Jensen EV 1981 Hormone dependency of breast cancer. Cancer 47:2319-2326
24. McGuire WL, Clark GM, Dressler LG, Owens MA 1986 Kole of steroid hormone receptors as prognosis factors in primary breast cancer. Natl Cancer Inst Monogr 1:19-23
25. Schonbrunn A 1982 Glucocorticoicls down-regulate somatostatin receptors on pituitary cells in culture. Endocrinology 110:1147-1154
26. Wakeling AE 1993 Are breast tumours resistant to tamoxifen also resistant to pure antioestrogens? J Steroid Biochem Mol Biol 47:107-114
27. Green S 1990 Modulation of oestrogen receptor activity by oestrogen and anti-oestrogens. J Steroid Biochem Mol Biol 37:747-751
28. Horowitz KB 1994 How do breast cancers become hormone resistant? J Steroid Biochem Mol Biol 49:295-302
29. Morrow M, Jordan VC 1993 Molecular mechanism of resistance to tamoxifen therapy in breast cancer. Arch Surg 128:1187-1191
30. Fujimoto N, Katzenellenbogen BS 1994 Alteration in the agonist/antagonist balance of antiestrogens by activation of protein kinase A signaling pathways in breast cancer cells: antiestrogen selectivity and promoter dependence. Mol Endocrinol 8:296-304
31. Catherino WH, Jordan 1995 Increasing the number of tandem estrogen response elements increases the estrogenic activity of a tamoxifen analogue. Cancer Lett 92:39-47
32. Webb P, Lopez GN, Uht RM, Kushner PJ 1995 Tamoxifen activation of the estrogen receptor/AP-1 pathway: potential origin for the cell-specific estrogen-like etfects of antiestrogens. Mol Endocrinol 9:443-456
33. Greenwood MT, Robertson L-A, Patel YC 1995 Cloning of the gene encoding human somatostatin receptor 2: sequence analysis of the 5′-flanking promoter region. Gene 159:291-292
34. Weckbecker G, Tolcsvai L, Stolz B, Pollak M, Bruns C 1994 Somatostatin analogue octreotide enhances the antineoplastic effects of tamoxifen and ovariectomy on 7, 12-dimethylbenz a.anthracene-induced rat mammary carcinomas. Cancer Res 54:6334-6337